{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-008786","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2026-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.590936+00:00","generated_at":"2026-05-15T21:49:23.554770+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Tevogen Bio announces 1-for-50 reverse stock split effective March 6, 2026 to regain Nasdaq compliance","bullets":["Reverse stock split ratio 1-for-50; effective 12:01 a.m. March 6, 2026.","Pre-split shares outstanding: 202,416,556 as of March 3, 2026.","Directors and executive officers beneficially own >70% of common stock.","No fractional shares issued; cash paid in lieu based on closing price day before effective date.","Authorized shares unchanged at 800M; symbol TVGN remains; new CUSIP 88165K200."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-008786","json":"https://secwatch.observer/filing/0001493152-26-008786.json","markdown":"https://secwatch.observer/filing/0001493152-26-008786.md","text":"https://secwatch.observer/filing/0001493152-26-008786.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:49:23.554770+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"189c504cb95c01ff7e449b7d59552998297819a7","claim":"Tevogen Bio Holdings Inc.: Effected a 1-for-50 reverse stock split by filing a Certificate of Amendment to the Certificate of Incorporation, effective March 6, 2026 (effective 2026-03-06).","evidence_excerpt":"On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001062993-26-002388","ticker":"WAMFF","company_name":"Alaska Silver Corp.","filed_at":"2026-05-07T23:59:59+00:00","headline":"Alaska Silver simplifies capital structure, eliminates dual-class shares","event_type":"other_material","sec_items":["3.03","5.03","7.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-26-002388","json":"https://secwatch.observer/filing/0001062993-26-002388.json","markdown":"https://secwatch.observer/filing/0001062993-26-002388.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/0001062993-26-002388-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/form8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm","comparable_excerpt":"On May 6, 2026, the Board of Directors of Alaska Silver Corp. (the \"Company\"), approved an amendment (the \"Amendment\") to the Company's Articles of the Company to eliminate its dual-class share structure by (i) eliminating its proportionate voting share class and (ii) reidentifying its subordinate voting share class as the class of \"Common Shares,\" no par value, of which the Company shall be authorized to issue an unlimited number of Common Shares.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/0001062993-26-002388-index.htm"}},{"accession":"0001104659-26-057200","ticker":"CUK","company_name":"CARNIVAL PLC","filed_at":"2026-05-07T23:59:59+00:00","headline":"Carnival completes DLC unification and redomiciliation to Bermuda; Carnival plc now a subsidiary","event_type":"other_material","sec_items":["1.02","2.01","3.01","3.02","3.03","5.01","5.03","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-057200","json":"https://secwatch.observer/filing/0001104659-26-057200.json","markdown":"https://secwatch.observer/filing/0001104659-26-057200.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1125259/000110465926057200/0001104659-26-057200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/815097/000110465926057200/tm2613680d1_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm","comparable_excerpt":"In addition, Carnival Corporation also migrated its jurisdiction of incorporation from the Republic of Panama to Bermuda and changed its name to \"Carnival Corporation Ltd.\" (the \"Redomiciliation\" and, together with the DLC Unification, the \"DLC Unification and Redomiciliation Transactions\").","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1125259/000110465926057200/0001104659-26-057200-index.htm"}},{"accession":"0001104659-26-055632","ticker":"ENZN","company_name":"Viskase Holdings, Inc.","filed_at":"2026-05-05T23:59:59+00:00","headline":"Viskase Holdings adopts Section 382 Rights Plan to protect NOL assets; threshold at 4.9%","event_type":"other_material","sec_items":["1.01","3.03","5.03","7.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-055632","json":"https://secwatch.observer/filing/0001104659-26-055632.json","markdown":"https://secwatch.observer/filing/0001104659-26-055632.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/727510/000110465926055632/0001104659-26-055632-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/727510/000110465926055632/tm2613382d1_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm","comparable_excerpt":"In connection with the adoption of the Section 382 Rights Agreement, the Board approved a Certificate of Designation of Series A-2 Junior Participating Preferred Stock of Viskase Holdings, Inc. (the “Certificate of Designation”). The Certificate of Designation was filed with the Secretary of the State of Delaware on May 5, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/727510/000110465926055632/0001104659-26-055632-index.htm"}},{"accession":"0001104659-26-053557","ticker":"CWEN","company_name":"Clearway Energy, Inc.","filed_at":"2026-05-01T23:59:59+00:00","headline":"Clearway Energy eliminates Class A stock; converts all shares to reduced-vote Class C","event_type":"other_material","sec_items":["1.01","3.03","5.03","5.07","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-053557","json":"https://secwatch.observer/filing/0001104659-26-053557.json","markdown":"https://secwatch.observer/filing/0001104659-26-053557.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567683/000110465926053557/0001104659-26-053557-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567683/000110465926053557/tm2613249d1_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm","comparable_excerpt":"Following the Class A Conversion, on May 1, 2026, the Company filed with the Delaware Secretary of State a certificate of retirement pursuant to Section 243 of the DGCL (the “Certificate of Retirement”) to retire all shares of Class A common stock converted in the Class A Conversion, which also had the effect of amending the Amended Charter to (i) reduce the total number of authorized shares of Class A common stock from 34,613,853 to zero, (ii) reduce the total number of authorized shares of capital stock of the Company from 2,544,613,853 to 2,510,000,000 and (iii) eliminate from the Amended Charter all references to the Class A common stock (collectively, the “Class A Retirement”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1567683/000110465926053557/0001104659-26-053557-index.htm"}},{"accession":"0001287032-26-000174","ticker":"PSEC","company_name":"PROSPECT CAPITAL CORP","filed_at":"2026-05-08T23:59:59+00:00","headline":"Prospect Capital enters $400M at-the-market preferred stock offering; reclassifies 16M common shares","event_type":"other_material","sec_items":["1.01","3.03","5.03","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001287032-26-000174","json":"https://secwatch.observer/filing/0001287032-26-000174.json","markdown":"https://secwatch.observer/filing/0001287032-26-000174.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1287032/000128703226000174/0001287032-26-000174-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1287032/000128703226000174/psec-20260508.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm","comparable_excerpt":"On May 8, 2026, in connection with the Offering, the Company filed Articles Supplementary (the “Articles Supplementary”) with the State Department of Assessments and Taxation of Maryland (“SDAT”), reclassifying and designating 16,000,000 authorized and unissued shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), into shares of Series A Preferred Stock.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1287032/000128703226000174/0001287032-26-000174-index.htm"}},{"accession":"0001193125-26-207628","ticker":"BNZI","company_name":"Banzai International, Inc.","filed_at":"2026-05-06T23:59:59+00:00","headline":"Banzai announces 1-for-20 reverse stock split effective May 8, 2026 to maintain Nasdaq compliance","event_type":"other_material","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-207628","json":"https://secwatch.observer/filing/0001193125-26-207628.json","markdown":"https://secwatch.observer/filing/0001193125-26-207628.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826011/000119312526207628/0001193125-26-207628-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826011/000119312526207628/bnzi-20260505.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm","comparable_excerpt":"On April 28, 2026, the Company filed a Certificate of Amendment to its COI with the Secretary of State of Delaware (the “Certificate of Amendment”), for the Reverse Stock Split at a ratio of 1-for-20.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826011/000119312526207628/0001193125-26-207628-index.htm"}},{"accession":"0001193125-26-204723","ticker":"MTNE","company_name":"CH4 Natural Solutions Corp","filed_at":"2026-05-05T23:59:59+00:00","headline":"CH4 Natural Solutions Corporation prices $200M IPO; begins trading on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","7.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-204723","json":"https://secwatch.observer/filing/0001193125-26-204723.json","markdown":"https://secwatch.observer/filing/0001193125-26-204723.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/0001193125-26-204723-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/d211764d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm","comparable_excerpt":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Company’s Amended and Restated Memorandum and Articles of Association (as so amended, the “ Memorandum and Articles ”) were approved on April 30, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2044817/000119312526204723/0001193125-26-204723-index.htm"}},{"accession":"0001628280-26-030618","ticker":"AAWH","company_name":"Ascend Wellness Holdings, Inc.","filed_at":"2026-05-05T23:59:59+00:00","headline":"Ascend Wellness Holdings completes Class B conversion and annual meeting","event_type":"other_material","sec_items":["3.03","5.03","5.07","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-030618","json":"https://secwatch.observer/filing/0001628280-26-030618.json","markdown":"https://secwatch.observer/filing/0001628280-26-030618.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756390/000162828026030618/0001628280-26-030618-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756390/000162828026030618/aawh-20260429.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm","comparable_excerpt":"On May 5, 2026, the Company filed a Certificate of Retirement with the Secretary of State of the State of Delaware (the “Certificate of Retirement”) to effect the retirement of the 65,000 shares of Class B Common Stock that were issued but no longer outstanding following the Conversion. Pursuant to Section 243(b) of the DGCL, upon its effectiveness, the Certificate of Retirement had the effect of amending the Certificate of Incorporation to reduce the total number of authorized shares of common stock of the Company by 65,000, to 750,035,000, and to reduce the number of authorized shares of Class B Common Stock by 65,000, to 35,000.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1756390/000162828026030618/0001628280-26-030618-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}